Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.

Wasil LR, Shair KHY.

J Virol. 2018 Aug 29;92(18). pii: e00557-18. doi: 10.1128/JVI.00557-18. Print 2018 Sep 15.

2.

Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation.

Caves EA, Butch RM, Cook SA, Wasil LR, Chen C, Di YP, Lee N, Shair KHY.

mSphere. 2017 Nov 8;2(6). pii: e00453-17. doi: 10.1128/mSphereDirect.00453-17. eCollection 2017 Nov-Dec.

3.
4.

Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.

Wasil LR, Wei L, Chang C, Lan L, Shair KH.

J Virol. 2015 Aug;89(15):7612-24. doi: 10.1128/JVI.00958-15. Epub 2015 May 13.

5.

The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection.

Wasil LR, Tomaszewski MJ, Hoji A, Rowe DT.

PLoS One. 2013;8(1):e54010. doi: 10.1371/journal.pone.0054010. Epub 2013 Jan 8.

6.

Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines.

Davies ML, Xu S, Lyons-Weiler J, Rosendorff A, Webber SA, Wasil LR, Metes D, Rowe DT.

Virology. 2010 Apr 25;400(1):53-67. doi: 10.1016/j.virol.2010.01.002. Epub 2010 Feb 11.

7.

Control of phage Bxb1 excision by a novel recombination directionality factor.

Ghosh P, Wasil LR, Hatfull GF.

PLoS Biol. 2006 Jun;4(6):e186.

Supplemental Content

Loading ...
Support Center